Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Long-term treatment with lebrikizumab may be beneficial for patients with atopic dermatitis that were not initially ...

A novel study showed that spontaneous neural activity and functional connectivity in certain brain regions correlated with ...

The following is a summary of “Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque ...

T wo recent studies are helping to explain the benefits of exercise and its ability to control your hunger cravings—a hot ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...

In cancer-associated cachexia, elevated TNF-α and IL-6 exacerbate muscle and fat loss by regulating multiple metabolic signaling pathways, which could be ameliorated by Z526's suppression of NF-κB ...

The layoffs follow an announcement in early January that I-Mab will re-prioritize resources to focus on advancing a CLDN18.2 ...

AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...

The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.